AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.
about
Trash or Treasure: extracellular microRNAs and cell-to-cell communicationRole and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular BiologyCirculating microRNAs: a potential role in diagnosis and prognosis of acute myocardial infarctionMicroRNAs in flow-dependent vascular remodellingDeveloping miRNA therapeutics for cardiac repair in ischemic heart diseaseExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Dysregulated miR-361-5p/VEGF axis in the plasma and endothelial progenitor cells of patients with coronary artery diseaseMicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1Exosomes: Fundamental Biology and Roles in Cardiovascular PhysiologyExosomal miRNAs as potential biomarkers of cardiovascular risk in children.Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cellsMolecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes.The association between circulating microRNA levels and coronary endothelial function.Age- and glycemia-related miR-126-3p levels in plasma and endothelial cells.microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.Changes in circulating microRNA-126 during treatment with chemotherapy and bevacizumab predicts treatment response in patients with metastatic colorectal cancer.MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease.Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation.Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus.Metabolism Regulates Cellular Functions of Bone Marrow-Derived Cells used for Cardiac Therapy.MiR-126 Contributes to Human Umbilical Cord Blood Cell-Induced Neurorestorative Effects After Stroke in Type-2 Diabetic MiceMicrovesicles and diabetic complications--novel mediators, potential biomarkers and therapeutic targets.Exosomes and exosomal miRNAs in cardiovascular protection and repair.The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathwayMicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease.Concise review: MicroRNAs as modulators of stem cells and angiogenesis.Insulin resistance, diabetes, and cardiovascular risk.Molecular pathways of arterial aging.MicroRNAs in myocardial infarction.Exosome and its roles in cardiovascular diseases.Extracellular vesicles and atherosclerotic disease.Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes.The multifactorial nature of microRNAs in vascular remodelling.Circulating microRNAs in acute and chronic exercise: more than mere biomarkers.Extracellular Vesicles and Vascular Injury: New Insights for Radiation Exposure.Macro- and microvascular endothelial dysfunction in diabetes.Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.Dissecting microRNA dysregulation in age-related macular degeneration: new targets for eye gene therapy.Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.
P2860
Q21131238-A900784D-6947-4179-9E0E-91E0E1E76A65Q26777595-27D15253-AD82-4E0F-A3FE-93FFB95CB487Q26862733-3F8E8D48-4A8D-464F-BCC8-2476B4F91AC9Q27002530-7080E149-F7EE-4B72-BBFF-9B7F1F2B80C7Q28077986-445150E8-3125-4B12-BD71-AEB5101755AFQ28079163-D148DCBE-BE92-435A-937F-3B34AE766501Q28539143-7A0BCFD4-DB64-4248-A2F1-4EFFCCDDF94AQ30414327-2D996E7A-205E-4D02-8252-CC27CBF35FDBQ33657616-A9BF8AEC-6D0B-437B-945E-98D069F9ABEDQ33756578-6DD0C595-1D0D-4549-9944-BA10375BA3F3Q33995548-42BC94E0-45C6-45F8-BE66-6787F0B18A57Q34099937-44F9D713-2F1E-415B-A0D1-5925864EE6EEQ34332008-1149911D-F5C1-48FC-890D-F9B3F3F0D67CQ34461150-86C58CFE-5B05-4D0D-A17D-C3F51FE48651Q34504964-4ABEDA4E-F76C-4508-A08D-703038266F1DQ35098328-1091B5DA-4618-4B2B-AC90-DE512208A28BQ35114995-C4EA4036-3EE6-42CA-96E7-21BCB44FDB17Q35665925-AAEAC697-3D5C-4016-9474-ABE8CAC0ADA5Q35966986-87E8AB20-D8D3-4FE1-8DD5-EA700AAE4207Q36008423-663508EF-9FE1-4707-B23C-8EF63ED7812DQ36464003-CB90B7CF-D4A6-400D-9267-97996E64721FQ36745194-76F35C31-08B2-4B1E-B9D3-E8B425E98032Q36816939-661E295B-5A54-4B2A-8E68-8FF1C9F846B6Q36975014-DF5B2656-B4C7-4A3B-9115-67E15C59A197Q38115105-7B79BAC0-F5B7-4FB5-BDED-6B26258E40C2Q38180628-41B3EEFF-B8A2-4659-905C-B2273C33F285Q38208221-9F4F988B-789C-40B3-BBE5-D6C611BA2A5DQ38252544-5722814F-262B-478F-8FC3-2F92C3C05870Q38289373-CD8EA7CC-5278-4284-AD1B-53CD9D7213EFQ38304096-DAEADE9D-A5C7-4154-BEF9-94A469236ADFQ38430673-C42F0EDB-1F6E-48B5-8111-01A74DFC3CDDQ38537772-01A2B119-7B69-41AE-94B0-AAC0B00F1EB5Q38749173-3073FB5D-4470-46CA-AABA-EA5F973256F9Q38776396-AE538F51-F74D-4116-9D4C-64E74969D733Q38908954-A0D8E46D-C784-4CFB-823B-77B7F255C719Q39065434-5E80D43A-6A7E-4EF4-B2FC-3994EF7B20D9Q39076891-904C4601-3929-4384-9210-19D415331A67Q39095744-0EB9ED9E-B6EA-4CCC-8943-E1B2324BC235Q39167698-73ADFECC-F12E-4679-9309-093DDABEFBEDQ39190427-60C8686D-9878-4C61-83EC-579DD81A1B47
P2860
AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
AngiomiR-126 expression and secretion from circulating CD34
@nl
AngiomiR-126 expression and se ...... terations in type 2 diabetics.
@en
type
label
AngiomiR-126 expression and secretion from circulating CD34
@nl
AngiomiR-126 expression and se ...... terations in type 2 diabetics.
@en
prefLabel
AngiomiR-126 expression and secretion from circulating CD34
@nl
AngiomiR-126 expression and se ...... terations in type 2 diabetics.
@en
P2093
P1433
P1476
AngiomiR-126 expression and se ...... terations in type 2 diabetics.
@en
P2093
Carola Dörries
Francesco Paneni
Giovanna Giannotti
Pavani Mocharla
Philipp Jakob
Sylvie Briand
Thomas Lüscher
P304
P356
10.1182/BLOOD-2012-01-407106
P407
P577
2012-11-08T00:00:00Z